If you have systemic mastocytosis, your health care provider may recommend a medicine to treat it. One such medicine is Ayvakit (avapritinib), an oral tablet. Systemic mastocytosis is a rare condition ...

Long-term data from the PIONEER trial, presented at the American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting, support the durability of response with the KIT inhibitor avapritinib ...

The KIT inhibitor avapritinib (Ayvakit) maintained symptom improvement and reduced mast cell burden in patients with indolent ...

Mastocytosis is a rare condition where an excessive amount of mast cells gather in the organs and tissues of the body. It can affect the skin, lymph nodes, bone marrow, and other organ systems. Mast ...

Systemic mastocytosis is a rare blood cancer in which abnormal mast cells (a type of white blood cell) build up in your skin and other organs. You might get a variety of symptoms, including itchy skin ...

Advanced systemic mastocytosis is a progressive condition characterized by the accumulation of mast cells in the body’s organs. There’s no cure for advanced systemic mastocytosis, but many of the ...

The prognosis for advanced systemic mastocytosis is daunting: It most often includes a shortened life expectancy and difficult-to-manage symptoms. But many people with the condition have lived with ...

Bezuclastinib is an oral, selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation, a primary driver of ...

Cutaneous mastocytosis is one of two types of mastocytosis, a rare disorder in which too many mast cells — a type of white blood cell that helps the immune system function properly — accumulate in the ...

This page lists all known medications that could potentially lead to 'Mastocytosis' as a side effect. It's important to note that mild side effects are quite common with medications. The medication(s) ...

Mast cells develop from hematopoietic progenitors in response to stem-cell factor (KIT ligand), which is the ligand of the CD117 transmembrane tyrosine kinase receptor, encoded by KIT. CD117 regulates ...

Systemic mastocytosis is a myeloid neoplasm divided into six subcategories by the recent classification by WHO. It involves the accumulation of abnormal mast cells (MCs) in the skin, liver, spleen, ...